EP Patent

EP4624054A3 — Methods for generating and delivering droplets to the pulmonary system using a droplet delivery device

Assigned to Pneuma Respiratory Inc · Expires 2025-11-19 · 0y expired

What this patent protects

A droplet delivery device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The droplet delivery device includes a housing, a reservoir, and ejector mechanism, and at least one differential pressure sensor. The droplet …

USPTO Abstract

A droplet delivery device and related methods for delivering precise and repeatable dosages to a subject for pulmonary use is disclosed. The droplet delivery device includes a housing, a reservoir, and ejector mechanism, and at least one differential pressure sensor. The droplet delivery device is automatically breath actuated by the user when the differential pressure sensor senses a predetermined pressure change within housing. The droplet delivery device is then actuated to generate a stream of droplets having an average ejected droplet diameter within the respirable size range, e.g, less than about 5 µm, so as to target the pulmonary system of the user.

Drugs covered by this patent

Patent Metadata

Patent number
EP4624054A3
Jurisdiction
EP
Classification
Expires
2025-11-19
Drug substance claim
No
Drug product claim
No
Assignee
Pneuma Respiratory Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.